Pharmaceutical stocks sank lower Wednesday after President Trump doubled down on his promise to slap tariffs on a long-exempt industry, causing market turmoil globally.

Though the pharma stocks have come down significantly from 1-year highs, the investors are still looking for bargain buys. Moreover, the selling pressure has been further exacerbated by the lack ...

One possible scenario is Trump introduces tariffs specifically targeting pharma—either all at once, or in stages—said Huynh. The president could also pursue tax reform aimed at the industry ...